AV7909

AV7909 [anthrax vaccine adsorbed (AVA), adjuvant] is being studied for use as a third generation anthrax vaccine. This candidate consists of BioThrax® (Anthrax Vaccine Adsorbed) in combination with a novel immunostimulatory compound, CPG 7909.

Notify me on updates of this product 

Availability: In Development

Rebecca Fish
Vice President of Marketing & Product Strategy
fishr@ebsi.com
+1 240 631 3200
400 Professional Drive, Suite 400
Gaithersburg, MD 20879
USA
www.emergentbiosolutions.com/our-products
Manufacturer
Emergent BioSolutions, Inc.
Product Name
AV7909
Detection Category
Biological
Detection Method
Medical Countermeasure
Application
Personal Protective Equipment;
Equipment Type
PPE
Product Synopsis
AV7909 [anthrax vaccine adsorbed (AVA), adjuvant] is being studied for use as a third generation anthrax vaccine. This candidate consists of BioThrax® (Anthrax Vaccine Adsorbed) in combination with a novel immunostimulatory compound, CPG 7909.
Availability
In Development
Technology Readiness Level (TRL)
7
User Feedback Sources
Indifferent/No user feedback
Weight
<1 lb.
Power Requirements
None
Transportability
Pocket Size
Live Agent Tested
Yes; B. anthracis (anthrax)
Material
BioThrax® (Anthrax Vaccine Adsorbed) in combination with a immunostimulatory compound, CPG 7909.
Operating Time
Preventative administration prior to exposure
Training Required
<1 hour training
Manuals Available
Yes
Please enter contact info.
Email Address: 
Company: 
Name: 
Title: